FLNA
Filana Therapeutics, Inc.
Filana Therapeutics, Inc. insider trading
Insiders at Filana Therapeutics, Inc. have been buying its stock on the open market. The largest purchase in the last 30 days was Barry Richard (President & CEO · Director) buying $78.2K of FLNA, filed Sep 30, 2026. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.
- Bought on the open market
- $78.2K
- Sold
- —
- Insiders
- 1
- Latest trade
- Sep 28, 2026
From SEC filings · last 30 days
Recent FLNA insider transactions
Barry RichardPresident & CEO · Director
Bought 93,091 sh at $0.84 · Sep 28, 2026
$78.2K
Filing
SEC Form 4 data, Q3 2024 to Q2 2026
FLNA insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 5 insiders traded FLNA on the open market: 9 purchases worth $1.2M and 3 sales worth $253.9K. In the last four quarters alone: 9 purchases ($1.2M) and 0 sales, by 3 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | — | — | |
| Q1 2026 | — | — | |
| Q4 2025 | +$640.7K3 buys | — | |
| Q3 2025 | +$591K6 buys | — | |
| Q2 2025 | — | — | |
| Q1 2025 | — | — | |
| Q4 2024 | — | −$253.9K3 sales | |
| Q3 2024 | — | — |
- Largest purchase
- +$414.9K of FLNA by Barry Richard (President & CEO · Director) on Sep 18, 2025.
- Largest sale
- −$230.8K of FLNA by Schoen Eric (Chief Financial Officer) on Nov 29, 2024.
Open-market transactions through Jun 30, 2026most recent first
Anderson Robert Eugene Jr
Director
+$24.9K
Nov 24, 2025
8,600 sh · $2.90
Barry Richard
President & CEO · Director
+$414K
Nov 20, 2025
150,000 sh · $2.76
Barry Richard
President & CEO · Director
+$201.8K
Nov 19, 2025
73,385 sh · $2.75
Cook Robert Christopher
Chief Operating & Legal Office
+$39.9K
Sep 30, 2025
13,725 sh · $2.91
Barry Richard
President & CEO · Director
+$16.4K
Sep 22, 2025
7,172 sh · $2.28
Barry Richard
President & CEO · Director
+$107.4K
Sep 19, 2025
46,908 sh · $2.29
Barry Richard
President & CEO · Director
+$900
Sep 19, 2025
400 sh · $2.25
Barry Richard
President & CEO · Director
+$414.9K
Sep 18, 2025
185,233 sh · $2.24
Barry Richard
President & CEO · Director
+$11.5K
Sep 18, 2025
5,400 sh · $2.13
Schoen Eric
Chief Financial Officer
−$230.8K
Nov 29, 2024
59,800 sh · $3.86
Kupiec James William
Chief Medical Officer
−$15.5K
Nov 29, 2024
4,000 sh · $3.87
Schoen Eric
Chief Financial Officer
−$7.6K
Nov 29, 2024
2,000 sh · $3.82
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Nov 24, 2025 | Anderson Robert Eugene JrDirector | 8,600 | $2.90 | +$24.9K |
| Nov 20, 2025 | Barry RichardPresident & CEO · Director | 150,000 | $2.76 | +$414K |
| Nov 19, 2025 | Barry RichardPresident & CEO · Director | 73,385 | $2.75 | +$201.8K |
| Sep 30, 2025 | Cook Robert ChristopherChief Operating & Legal Office | 13,725 | $2.91 | +$39.9K |
| Sep 22, 2025 | Barry RichardPresident & CEO · Director | 7,172 | $2.28 | +$16.4K |
| Sep 19, 2025 | Barry RichardPresident & CEO · Director | 46,908 | $2.29 | +$107.4K |
| Sep 19, 2025 | Barry RichardPresident & CEO · Director | 400 | $2.25 | +$900 |
| Sep 18, 2025 | Barry RichardPresident & CEO · Director | 185,233 | $2.24 | +$414.9K |
| Sep 18, 2025 | Barry RichardPresident & CEO · Director | 5,400 | $2.13 | +$11.5K |
| Nov 29, 2024 | Schoen EricChief Financial Officer | 59,800 | $3.86 | −$230.8K |
| Nov 29, 2024 | Kupiec James WilliamChief Medical Officer | 4,000 | $3.87 | −$15.5K |
| Nov 29, 2024 | Schoen EricChief Financial Officer | 2,000 | $3.82 | −$7.6K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Don't check FLNA — let it ping you
Watch every insider filing the minute it clears the SEC
The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.
Filana Therapeutics, Inc. is outside the 777 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.
Other companies insiders are buying now
Questions
- Are FLNA insiders buying or selling?
- Between Sep 28, 2026 and Sep 28, 2026, 1 Filana Therapeutics, Inc. insider made 1 open-market purchase worth $78.2K and no sales, a net purchase of $78.2K.
- How much FLNA stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 5 Filana Therapeutics, Inc. insiders made 9 open-market purchases worth $1.2M and 3 sales worth $253.9K. In the four quarters to Jun 30, 2026: 9 purchases ($1.2M) and no sales. The largest purchase was Barry Richard buying $414.9K on Sep 18, 2025. The largest sale was Schoen Eric selling $230.8K on Nov 29, 2024.
- What was the largest recent FLNA insider trade?
- Barry Richard (President & CEO · Director) bought $78.2K of FLNA stock on Sep 28, 2026 at about $0.84 a share.
- When did an insider last buy FLNA shares?
- The most recent open-market purchase on file is Barry Richard (President & CEO · Director) buying $78.2K on Sep 28, 2026.
- Where does FLNA insider trading data come from?
- From the Form 4 filings Filana Therapeutics, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.